Rosiglitazone inhibition of calvaria-derived osteoblast differentiation is through both of PPARγ and GPR40 and GSK3β-dependent pathway

出版年份 2015 全文链接

标题

作者

关键词

Rosiglitazone, Osteoblast, PPARγ, GPR40, GSK3β

出版物

MOLECULAR AND CELLULAR ENDOCRINOLOGY

Volume 413, Issue -, Pages 78-89

出版商

Elsevier BV

发表日期

2015-06-25

DOI

10.1016/j.mce.2015.06.013

向作者/读者发起求助以获取更多资源

Protocol

在线求助

Reagent

在线求助

Reprint

联系作者

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.